Vaxart, Inc. Treasury Stock, Value
Vaxart, Inc. (VXRT) had Treasury Stock, Value of $117.05 million as of 2013-03-31, per its 10-Q filed 2013-05-10.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:TreasuryStockValue · last filed 2013-09-27
- 2013-03-31: Treasury Stock, Value $117.05M.
- 2012-12-31: Treasury Stock, Value $117.05M.
- 2012-09-30: Treasury Stock, Value $117.05M.
- 2012-06-30: Treasury Stock, Value $1.40M; Treasury Stock, Value as first filed $92.57M.
| Period end | Treasury Stock, Value | Treasury Stock, Value as first filed |
|---|---|---|
| 2013-03-31 | $117.05M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $117.05M 10-Q · filed 2013-02-11 | |
| 2012-09-30 | $117.05M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $1.40M 10-K · filed 2013-09-27 | $92.57M 10-Q · filed 2012-08-09 |
| 2012-03-31 | $92.57M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $92.57M 10-Q · filed 2012-11-08 | |
| 2011-09-24 | $92.57M 10-Q · filed 2011-11-02 | |
| 2011-06-25 | $92.57M 10-Q · filed 2011-08-03 | |
| 2010-12-25 | $92.57M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |